Multiple Myeloma Patients Remain On Treatment Far Less than in Clinical Trials, Study Finds
Patients with relapsed or refractory multiple myeloma who are…
Myeloma
Myeloma overview
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreMyeloma treatment
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreLatest news
Empliciti Improves Response to Combo Treatment in Newly Diagnosed Myeloma Patients, Study Finds
Newly diagnosed multiple myeloma patients respond better to…
FDA Extends Xgeva Approval to Include Myeloma Patients with Bone Lesions
The U.S. Food and Drug Administration (FDA) has agreed…
Dual-targeted CAR T-cell Therapy Shows Promising Anti-tumor Response in Mice
A preclinical study has shown that a new dual-targeting APRIL…
Janssen and Legend Biotech Joining Forces to Advance Myeloma CAR T-cell Therapy
Janssen Biotech and China’s Legend Biotech are teaming…
BioLineRx Readies Phase 3 Myeloma Trial to Mobilize Stem Cells for Transplant
BioLineRx has launched a Phase 3 trial to…
